The new insights into autophagy in thyroid cancer progression.

Autophagy Autophagy inhibitor Cancer progression Targeted therapy Thyroid cancer

Journal

Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741

Informations de publication

Date de publication:
24 06 2023
Historique:
received: 15 03 2023
accepted: 09 06 2023
medline: 26 6 2023
pubmed: 25 6 2023
entrez: 24 6 2023
Statut: epublish

Résumé

In recent decades, the incidence of thyroid cancer keeps growing at a shocking rate, which has aroused increasing concerns worldwide. Autophagy is a fundamental and ubiquitous biological event conserved in mammals including humans. Basically, autophagy is a catabolic process that cellular components including small molecules and damaged organelles are degraded for recycle to meet the energy needs, especially under the extreme conditions. The dysregulated autophagy has indicated to be involved in thyroid cancer progression. The enhancement of autophagy can lead to autophagic cell death during the degradation while the produced energies can be utilized by the rest of the cancerous tissue, thus this influence could be bidirectional, which plays either a tumor-suppressive or oncogenic role. Accordingly, autophagy can be suppressed by therapeutic agents and is thus regarded as a drug target for thyroid cancer treatments. In the present review, a brief description of autophagy and roles of autophagy in tumor context are given. We have addressed summary of the mechanisms and functions of autophagy in thyroid cancer. Some potential autophagy-targeted treatments are also summarized. The aim of the review is linking autophagy to thyroid cancer, so as to develop novel approaches to better control cancer progression.

Identifiants

pubmed: 37355631
doi: 10.1186/s12967-023-04265-6
pii: 10.1186/s12967-023-04265-6
pmc: PMC10290383
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

413

Informations de copyright

© 2023. The Author(s).

Références

Cell. 2008 Jan 11;132(1):27-42
pubmed: 18191218
Oncogene. 2017 Mar 23;36(12):1619-1630
pubmed: 27593926
World J Gastroenterol. 2016 Oct 7;22(37):8361-8374
pubmed: 27729742
Cell. 2009 Jun 12;137(6):1062-75
pubmed: 19524509
J Clin Endocrinol Metab. 2015 May;100(5):E748-56
pubmed: 25710562
Mol Cancer. 2014 Jul 05;13:165
pubmed: 24996221
J Cell Sci. 2011 Jan 15;124(Pt 2):161-70
pubmed: 21187343
Oncogene. 2018 Mar;37(9):1142-1158
pubmed: 29255248
Nat Rev Endocrinol. 2021 Mar;17(3):176-188
pubmed: 33339988
Cancer Lett. 2020 Oct 10;490:143-153
pubmed: 32634449
Science. 2019 Nov 15;366(6467):818-822
pubmed: 31727826
Drugs. 2018 May;78(7):747-758
pubmed: 29663291
Front Oncol. 2021 Oct 27;11:739145
pubmed: 34778055
Surgery. 2022 Jan;171(1):235-244
pubmed: 34565609
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619890538
pubmed: 31771432
Acta Biochim Biophys Sin (Shanghai). 2020 Apr 20;52(4):382-389
pubmed: 32227107
Int J Cancer. 2015 May 1;136(9):2187-95
pubmed: 25284703
Br J Cancer. 2021 Jun;124(12):1900-1901
pubmed: 33767420
Surgery. 2009 Dec;146(6):1208-14
pubmed: 19958950
Carcinogenesis. 2013 Jun;34(6):1343-51
pubmed: 23430956
Genes Dev. 2016 Sep 1;30(17):1913-30
pubmed: 27664235
Head Neck. 2020 Aug;42(8):2181-2193
pubmed: 32129545
Breast Cancer Res Treat. 2019 Nov;178(2):327-335
pubmed: 31392517
Front Oncol. 2020 Mar 11;10:217
pubmed: 32219060
Endocrinol Metab Clin North Am. 2019 Mar;48(1):1-22
pubmed: 30717895
Front Oncol. 2021 Apr 15;11:638701
pubmed: 33937040
Cell Oncol (Dordr). 2021 Jun;44(3):611-625
pubmed: 33534128
Cell Death Dis. 2021 May 8;12(5):459
pubmed: 33966040
Oncogene. 2016 Jul 14;35(28):3619-25
pubmed: 26592449
Cell Death Dis. 2022 Feb 8;13(2):124
pubmed: 35136031
Cell Death Dis. 2018 Oct 9;9(10):1030
pubmed: 30301881
Autophagy. 2019 May;15(5):886-899
pubmed: 30782064
Lancet Oncol. 2016 Sep;17(9):1272-82
pubmed: 27460442
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Oncologist. 2014 Jun;19(6):637-8
pubmed: 24821822
J Exp Clin Cancer Res. 2015 Jul 22;34:69
pubmed: 26198850
Int J Biol Sci. 2022 May 16;18(9):3605-3620
pubmed: 35813472
Pathol Res Pract. 2022 Jan;229:153735
pubmed: 34922208
Phytother Res. 2022 Feb;36(2):938-950
pubmed: 35076979
Front Oncol. 2020 Aug 28;10:1265
pubmed: 32983963
Apoptosis. 2016 Apr;21(4):473-88
pubmed: 26767845
Int J Clin Exp Pathol. 2015 Sep 01;8(9):10824-31
pubmed: 26617795
Life Sci. 2021 Jan 15;265:118745
pubmed: 33186569
Cell Death Dis. 2019 Aug 13;10(8):612
pubmed: 31406106
Cell Death Dis. 2017 Jul 20;8(7):e2943
pubmed: 28726781
Cells. 2020 Mar 04;9(3):
pubmed: 32143356
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Clin Oncol (R Coll Radiol). 2017 May;29(5):316-324
pubmed: 28318881
In Vitro Cell Dev Biol Anim. 2019 May;55(5):341-348
pubmed: 31025250
Surgery. 2012 Dec;152(6):1142-9
pubmed: 23158184
J Clin Endocrinol Metab. 2017 Feb 1;102(2):634-643
pubmed: 27754804
Genes Cancer. 2014 Jul;5(7-8):226-39
pubmed: 25221641
Clin Cancer Res. 2020 Jul 1;26(13):3126-3134
pubmed: 32156749
Nat Rev Endocrinol. 2016 Nov;12(11):646-653
pubmed: 27418023
J Clin Endocrinol Metab. 2014 Nov;99(11):E2298-307
pubmed: 25062457
Autophagy. 2012 Feb 1;8(2):200-12
pubmed: 22252008
Autophagy. 2008 Aug;4(6):810-4
pubmed: 18604159
Endocrine. 2021 Feb;71(2):418-426
pubmed: 32666385
Cancer Sci. 2018 Aug;109(8):2576-2589
pubmed: 29908094
Autophagy. 2017 Feb;13(2):264-284
pubmed: 27929731
Endocrine. 2014 Mar;45(2):256-62
pubmed: 23821365
J Cell Biol. 2020 Jan 6;219(1):
pubmed: 31753861
Toxicol In Vitro. 2022 Feb;78:105254
pubmed: 34634291
Nat Cell Biol. 2006 Oct;8(10):1124-32
pubmed: 16998475
Nat Rev Drug Discov. 2012 Nov;11(11):873-86
pubmed: 23060265
Mol Cancer Res. 2010 Sep;8(9):1217-26
pubmed: 20736296
Pathol Res Pract. 2020 Jun;216(6):152950
pubmed: 32307199
J Biol Chem. 2007 Aug 17;282(33):24131-45
pubmed: 17580304
Endocr Relat Cancer. 2019 Aug 1;26(9):R499-R518
pubmed: 31252403
Antioxid Redox Signal. 2014 Jan 20;20(3):460-73
pubmed: 23725295
Mol Cancer. 2020 Jan 22;19(1):12
pubmed: 31969156
Dermatology. 2019;235(5):380-389
pubmed: 31269494
Cancers (Basel). 2021 Jul 15;13(14):
pubmed: 34298755
Autophagy. 2016 Jul 2;12(7):1195-205
pubmed: 27105307
Kaohsiung J Med Sci. 2018 May;34(5):255-262
pubmed: 29699632
Biomed Pharmacother. 2012 Dec;66(8):642-7
pubmed: 23089471
Cell Death Dis. 2021 Apr 1;12(4):347
pubmed: 33795650
Endocr J. 2022 Jul 28;69(7):847-862
pubmed: 35197412
Chin J Cancer. 2017 Jun 24;36(1):52
pubmed: 28646911
Blood. 2012 Oct 25;120(17):3555-62
pubmed: 22898604
Am J Cancer Res. 2020 Jan 01;10(1):78-94
pubmed: 32064154
Front Oncol. 2022 Mar 10;12:852424
pubmed: 35359388
J Nucl Med. 2019 Jan;60(1):9-15
pubmed: 30190306
JAMA Oncol. 2022 Feb 01;8(2):242-250
pubmed: 34913959
Int J Mol Sci. 2021 Jun 03;22(11):
pubmed: 34204950
Cancers (Basel). 2021 Dec 31;14(1):
pubmed: 35008368
J Mol Med (Berl). 2018 Aug;96(8):777-790
pubmed: 29942976
J Lipid Res. 2019 Feb;60(2):229-241
pubmed: 30397185
Autophagy. 2018;14(7):1110-1128
pubmed: 29863947
Mol Cell. 2011 Dec 9;44(5):698-709
pubmed: 22152474
Lancet. 2016 Dec 3;388(10061):2783-2795
pubmed: 27240885
Exp Ther Med. 2018 Apr;15(4):3537-3543
pubmed: 29545880
Oncogene. 2017 Feb 2;36(5):667-677
pubmed: 27375021
Int J Mol Sci. 2017 Aug 28;18(9):
pubmed: 28846632
J Transl Med. 2022 Feb 5;20(1):79
pubmed: 35123502
EMBO J. 2000 Nov 1;19(21):5720-8
pubmed: 11060023
Cell Death Dis. 2022 Jan 10;13(1):46
pubmed: 35013120
Cells. 2020 Dec 08;9(12):
pubmed: 33302403
Cell Death Differ. 2019 Mar;26(4):690-702
pubmed: 30728463
Pharmacol Res. 2017 Jan;115:288-298
pubmed: 27940017
Int J Biochem Cell Biol. 2004 Dec;36(12):2503-18
pubmed: 15325588
J Cancer. 2022 Jan 1;13(3):858-868
pubmed: 35154454
Nat Rev Mol Cell Biol. 2020 Aug;21(8):439-458
pubmed: 32372019
Int J Clin Exp Pathol. 2015 Jul 01;8(7):8291-7
pubmed: 26339399
Int J Clin Exp Pathol. 2019 Mar 01;12(3):885-892
pubmed: 31933897
Food Funct. 2015 Nov;6(11):3464-72
pubmed: 26292725
Mol Biol Cell. 2009 Apr;20(7):1981-91
pubmed: 19211835
Ann Transl Med. 2021 Jul;9(13):1083
pubmed: 34422995
Cell Mol Neurobiol. 2017 Apr;37(3):377-388
pubmed: 27260250
Thyroid. 2013 Oct;23(10):1277-83
pubmed: 23489023

Auteurs

Yu-Bo Shi (YB)

Department of Thyroid and Breast Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

Shu-Yuan Chen (SY)

Department of Thyroid and Breast Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

Ren-Bin Liu (RB)

Department of Thyroid and Breast Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. liur@vip.163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH